Mar 12 2025

Missouri Senate Committee Approves Medical Psilocybin Bill

The Missouri Senate Families, Seniors and Health Committee has approved Senate Bill 90, advancing a proposal that would provide legal access to psilocybin-assisted therapy for certain patients.

Filed in December by State Senator Stephen Webber (D), the bill now moves forward for further consideration in the legislature.

SB 90 would allow veterans suffering from PTSD, individuals with major depressive disorder or substance use disorder, and patients in end-of-life care to legally acquire and use psilocybin for therapeutic purposes. The measure establishes a framework requiring physician oversight, participation in a study on psilocybin’s effects, and adherence to safety protocols, including product testing.
Continue reading

Mar 12 2025

Georgia Lawmakers Introduce Bipartisan Bill to Regulate Kratom Sales

A bipartisan group of five Georgia lawmakers has introduced House Bill 757, a measure that would regulate the sale of kratom products in the state.

Filed today by Representatives Kelley, Jasperse, Kendrick, Ridley, and Mathis, the bill would require kratom processors to register their products annually with the Department of Agriculture and meet strict compliance standards.

Kratom, a plant native to Southeast Asia that’s been used for thousands of years, has gained popularity in the U.S. as a natural supplement. It is commonly used for its stimulant effects in low doses and its pain-relieving properties at higher doses. Many consumers say that kratom helps them relieve their pain, PTSD, and anxiety. It’s also commonly used as an alternative to opioids.
Continue reading

Mar 12 2025

Study Finds Cannabis Terpenes Effectively Treat Fibromyalgia and Post-Surgical Pain

A new government-funded study published in Pharmacology Reports has found that certain terpenes found in cannabis may provide effective relief for fibromyalgia and post-surgical pain.

The research, conducted by the University of Arizona Health Sciences and funded by the National Institutes of Health, builds on prior studies demonstrating terpenes’ pain-relieving properties in models of inflammation and neuropathy.

Led by John Streicher, PhD, the study tested four cannabis terpenes—geraniol, linalool, beta-caryophyllene, and alpha-humulene—on mice with induced fibromyalgia and post-surgical pain. Researchers found that all four terpenes significantly reduced pain levels, with geraniol producing the most pronounced effect. The findings suggest that these compounds may serve as non-opioid alternatives for managing chronic and post-surgical pain.
Continue reading

Mar 12 2025

Report: CBD-Infused Products Market Valued at $45 Billion, Expected to Grow to $291 Billion by 2032

According to a new market research report published by Meticulous Research, the CBD-infused products market is expected to reach a value of $291.39 billion by 2032, at a CAGR of 30.6% from 2025 to 2032.

The CBD-infused products market “is experiencing robust growth driven primarily by increasing consumer demand for cannabis products, expanding legalization across various jurisdictions, and growing popularity of cannabis-infused edibles”, states the report. However, “market expansion faces challenges from high production costs associated with cannabidiol (CBD) and regulatory restrictions in certain countries.”

Hemp is expected to account for 76.3% of the overall CBD-infused products market in 2025 and achieve the highest CAGR of 32.7% during the forecast period. This dominance is attributed to “hemp’s lower THC concentration, reduced psychoactive effects, and suitability for medical applications, along with its anti-inflammatory, anti-aging, and antioxidant properties.”
Continue reading

Mar 12 2025

The Fascinating History of CBD and How it was Discovered: From Ancient Times to Modern Science

By California Blendz

Understanding the Origins of CBD and its Historical Significance

CBD, short for cannabidiol, has gained significant attention in recent years for its potential health benefits. However, the history of CBD can be traced back much further than its modern-day popularity. In this section, we will delve into the discovery and historical significance of CBD, exploring its ancient uses and shedding light on how it has evolved over time.

To understand the history of CBD, we must first explore its discovery. CBD was first isolated and identified by Dr. Roger Adams and his team in 1940 at the University of Illinois. This groundbreaking discovery marked the beginning of scientific research into the compound’s properties and potential applications.
Continue reading

Mar 11 2025

New Mexico Bill to Legalize Medical Psilocybin Approved by Third Senate Committe

A third Senate committee has given approval to legislation that would legalize medical psilocybin, the active compound found in psychedelic mushrooms.

On Monday, the Senate Finance Committee voted in favor of Senate Bill 219, the Medical Psilocybin Act,
four days after the measure was advanced by the Senate Judiciary Committee. In February, the bill received approval by the Senate Tax, Business and Transportation Committee. The proposal now advances to the full Senate for consideration.

The proposed law would allow those in New Mexico with certain behavioral health conditions, including major treatment-resistant depression, post-traumatic stress disorder, substance use disorders, end-of-life care, and other conditions approved by the Department of Health, to receive psilocybin-assisted treatment for certain behavioral health conditions. The measure would establish an advisory board, a treatment equity fund, and a research fund while also removing psilocybin from the state’s Controlled Substances Act to protect “qualified and registered patients, clinicians and producers,” according to a news release from Senate and House Democrats.
Continue reading

Mar 11 2025

Florida Department of Health: State Has 902,566 Medical Marijuana Patients, Nearly 4% of Population

Nearly 4% of Florida’s population is registered as a medical marijuana patient, according to new data from state officials.

cannabis oil cbd

The Florida Department of Health reports that as of March 10, 902,566 individuals are qualified medical marijuana patients, representing 3.9% of the state’s 23.3 million residents.

This marks an increase of approximately 2,000 patients since the start of the year and 29,350 more patients compared to February 2024.
Continue reading

Mar 11 2025

Mississippi Legislature Approves Bill Revising Medical Cannabis Possession Limits and Allowing Telehealth for Homebound Patients

Mississippi’s legislature has approved Senate Bill 2748, a measure that revises key aspects of the state’s medical marijuana program.

Under current law, a Mississippi Medical Cannabis Equivalency Unit (MMCEU) is defined as 3.5 grams of medical marijuana flower, one gram of concentrate, or 100 milligrams of THC in an infused product (patients are allowed to obtain up to 24 MMCEUs within a 30-day period). Senate Bill 2748 revises this definition for the latter two, specifying that one MMCEU now consists of one gram of total THC in a concentrate, or one gram of total THC in an infused product.

The legislation also allows telemedicine evaluations for medical marijuana recommendations, provided the patient is homebound or bedbound and has this status certified by a separate practitioner. Additionally, SB 2748 alters the licensing process for medical marijuana businesses, prohibiting applicants from seeking local zoning or permitting approvals until they have first secured a state license from either the Mississippi Department of Health or the Mississippi Department of Revenue.
Continue reading

Mar 11 2025

Kansas Senate Committee Files Bill to Decriminalize Marijuana Possession

A Kansas Senate committee has introduced a bill that would eliminate criminal penalties for possessing small amounts of marijuana, marking another step toward potential reform in the state.

Filed today by the Senate Federal and State Affairs Committee, Senate Bill 295 would replace criminal charges for possessing a personal-use quantity of marijuana with a civil penalty. The measure comes just days after the same committee introduced a separate bill to legalize medical marijuana.

Under SB 295, individuals found with up to an ounce of marijuana would no longer face criminal prosecution. Instead, they would be subject to a civil fine, similar to a traffic ticket. Under current law, possessing even a single gram is punishable by a misdemeanor and up to six years in jail.
Continue reading

Mar 11 2025

Idaho Legislature Approves Resolution to Strip Voters of Power to Legalize Marijuana, Placing it on 2026 Ballot

The Idaho Senate has passed House Joint Resolution 4, finalizing its approval by the Legislature and securing its place on the November 2026 general election ballot.

HJR 4, which previously passed the House 58 to 10, was given approval by the Senate along party lines, with all 29 Republicans supporting the proposal and the six Demcorats opposed.

If approved by voters next year, the resolution would amend the state constitution to give the Legislature exclusive authority over the legalization of marijuana and other psychoactive substances. This would eliminate the public’s ability to legalize such substances through ballot initiatives.
Continue reading